Correlation Between BioNTech and Ameritrans Capital

Can any of the company-specific risk be diversified away by investing in both BioNTech and Ameritrans Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Ameritrans Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioNTech SE and Ameritrans Capital Corp, you can compare the effects of market volatilities on BioNTech and Ameritrans Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Ameritrans Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Ameritrans Capital.

Diversification Opportunities for BioNTech and Ameritrans Capital

0.01

Correlation Coefficient

BioNTech  Ameritrans Capital

Significant diversification

The 3 months correlation between BioNTech and Ameritrans is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Ameritrans Capital Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ameritrans Capital Corp and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Ameritrans Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ameritrans Capital Corp has no effect on the direction of BioNTech i.e., BioNTech and Ameritrans Capital go up and down completely randomly.

Pair Corralation between BioNTech and Ameritrans Capital

Given the investment horizon of 90 days BioNTech SE is expected to generate 0.22 times more return on investment than Ameritrans Capital. However, BioNTech SE is 4.46 times less risky than Ameritrans Capital. It trades about -0.01 of its potential returns per unit of risk. Ameritrans Capital Corp is currently generating about -0.12 per unit of risk. If you would invest  12,030  in BioNTech SE on October 8, 2024 and sell it today you would lose (451.00) from holding BioNTech SE or give up 3.75% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

BioNTech SE  vs.  Ameritrans Capital Corp

BioNTech SE

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, BioNTech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Ameritrans Capital Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ameritrans Capital Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Even with abnormal performance in the last few months, the Preferred Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with BioNTech and Ameritrans Capital

The main advantage of trading using opposite BioNTech and Ameritrans Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Ameritrans Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ameritrans Capital will offset losses from the drop in Ameritrans Capital's long position.

The idea behind BioNTech SE and Ameritrans Capital Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.